Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal second quarter ended September 30, 2025."Protein sales are gaining momentum as customers complete evaluations and transition to purchase orders," said Kip Underwood, Burcon's chief executive officer. "With recent production runs committed to multiple customers, w ...

Burcon Announces Non-Brokered Private Placement of Convertible Debentures and Execution of Loan AgreementNovember 12, 2025 8:00 AM EST | Source: Burcon NutraScience CorporationVancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce a non-brokered private placement of convertible debentures (the "Convertible Debent ...

Company Overview - Burcon NutraScience Corporation is a global technology leader in plant-based protein innovation, focusing on high-performance plant-based proteins for the food and beverage industry [5] - The company has a strong patent portfolio covering novel proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [5] Recent Developments - Burcon has successfully commenced commercial production of Puratein®C, a high-purity canola protein isolate with over 90% protein content, available for immediate delivery [1][3] - The production milestone is a significant step in Burcon's strategy to scale revenue and expand its portfolio of next-generation plant proteins [1][2] Product Details - Puratein C is extracted from non-GMO, North American-grown canola seeds and features a complete amino acid profile, including all nine essential amino acids [3] - The product has a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1, indicating its high nutritional value [3] - Puratein C is suitable for a wide range of applications, including dairy alternatives, ready-to-drink beverages, meat analogues, sauces, and baked goods [3] Market Opportunity - The global demand for high-quality, sustainable protein is accelerating, positioning Burcon's proprietary canola protein technology as a compelling solution [2] - The successful production of three proteins at commercial scale demonstrates Burcon's technology platform and execution capability, creating multiple new revenue streams [2]

Core Insights - Burcon Nutrascience Corporation has made significant advancements in its commercialization strategy during Q1 FY26, achieving first commercial production of Peazazz® C pea protein and launching FavaPro fava protein [1][6] - The company entered into a multi-year production agreement worth $6.8 million, which supports its revenue target of $1-3 million for 2025 [1][6] - The Galesburg facility utilizes Burcon's proprietary protein technologies, allowing for scalable production across various plant-based proteins, addressing a total addressable market for pea protein estimated between $215 million to $392 million [1][6] Financial Performance - Revenue for Q1 FY26 increased by 44% year-over-year, reaching $0.34 million [6] - Startup costs associated with the Galesburg facility have impacted margins, with expenses now stabilizing at "new normal" levels [6]

Core Insights - Burcon NutraScience Corporation is transitioning from a technology pioneer to a revenue-generating leader in plant protein innovation, with increased customer engagement and production scaling at the Galesburg facility [2][3]. Operational Highlights - The Galesburg facility achieved its first commercial production of next-generation proteins within 90 days of commissioning, securing a $6.8 million multi-year production agreement [3][4]. - Customer interest surged following the IFT FIRST tradeshow, positioning the company for consistent revenue growth as production ramps up [5][6]. Financial Performance - For the fiscal first quarter ended June 30, 2025, Burcon generated revenue of $342,000, a 44% increase from the same quarter last year, attributed to initial protein sales and contract manufacturing services [7]. - The company reported a net loss of $3.5 million, or $0.27 per share, compared to a net loss of $1.9 million, or $0.26 per share, in the prior year [9][17]. Cash Position and Liabilities - As of June 30, 2025, Burcon had $4.2 million in cash and committed to $1.3 million in payments under its manufacturing agreement for the Galesburg facility [10]. - Total liabilities amounted to $23.4 million, with current liabilities at $4.4 million [15]. Strategic Focus - The company aims to enhance production volumes and process efficiencies while converting its growing customer pipeline into long-term supply agreements [6]. - Burcon is committed to expanding its product portfolio and leading in plant protein innovation, leveraging its versatile production capabilities [6].

Core Insights - Burcon NutraScience Corporation has successfully achieved its first commercial production of FavaPro™, a high-purity fava protein isolate with over 90% protein content, marking a significant milestone in the company's growth strategy [1][3] - The launch of FavaPro™ is a response to the increasing consumer demand for healthy and sustainable protein alternatives, leveraging a proprietary process to extract and purify protein from fava beans, which are environmentally friendly and nutrient-rich [2][3] Company Overview - Burcon is recognized as a global technology leader in high-performance plant-based proteins, with a focus on delivering superior taste, texture, and functionality for the food and beverage industry [5] - The company has an extensive patent portfolio covering novel proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower, positioning it as a key player in the rapidly growing plant-based market [5] Product Features - FavaPro™ is naturally non-GMO, hypoallergenic, and features a neutral flavor profile, making it suitable for a wide range of food and beverage applications, including dairy alternatives, nutritional beverages, snacks, and baked goods [3] - The product is designed to meet the evolving needs of food formulators and eco-conscious consumers, delivering outstanding taste, color, nutrition, and sustainability [3]

Core Viewpoint - Burcon NutraScience Corporation is set to showcase its innovative Chipotle Black Bean Protein Hummus at the IFT FIRST Annual Event & Expo, highlighting its advancements in plant-based protein technology [1][6]. Group 1: Product Innovation - The Chipotle Black Bean Protein Hummus is crafted using Burcon's proprietary triple blend of Peazazz®C pea protein, Puratein®C canola protein, and Solatein™ sunflower protein, resulting in a dip that is both flavorful and nutritious [6][8]. - Burcon's plant-based proteins boast over 90% purity, neutral flavor, and smooth mouthfeel, making them suitable for various food applications [6][9]. Group 2: Event Details - The IFT FIRST event will take place in Chicago from July 13-16, 2025, where Burcon will be located at booth S4066 [1][6]. - Attendees will have the opportunity to sample the Chipotle Black Bean Protein Hummus during a special tasting event on July 14 and 15, from 11:00 AM to 1:00 PM [7][9]. Group 3: Company Background - Burcon NutraScience is recognized as a global leader in high-performance plant-based proteins, with a strong commitment to sustainability and innovation in the food and beverage industry [11]. - The company holds an extensive patent portfolio covering novel proteins derived from various plant sources, positioning itself as a key player in the growing plant-based market [11].